21 U.S.C. § 1710 — Drug Interdiction Coordinator and Committee

submitted 20 years ago by Pub. L. 105-277 to r/title-21-FOOD-AND-DRUGS · 847 words · no verdicts yet

in plain englishAI-generated · not legal advice

The Director must appoint a U.S. Interdiction Coordinator to lead federal drug interdiction efforts. The Coordinator issues a yearly plan and reports seizure and patrol data to Congress. An Interdiction Committee meets yearly to advise on strategy and report to Congress.

(a) The Director must appoint a senior official as the United States Interdiction Coordinator. This person coordinates efforts across all National Drug Control Program agencies. The goal is to stop illegal drugs from entering the country. This work must stay consistent with the national strategy. Each year by September 1, the Coordinator issues a National Interdiction Command and Control Plan. The Coordinator consults the Interdiction Committee first. The plan lays out the government's interdiction strategy. It states each agency's role. It identifies the resources needed. The Coordinator also judges whether agencies have committed enough resources to interdiction. The Coordinator advises the Director on how well agencies follow the plan. The Director assigns staff to help the Coordinator. The Director may also ask other agencies to detail staff. Each September 1, the Director must send Congress a report. That report includes that year's plan. It includes ten years of seizure statistics. It includes ten years of patrol-hour data. The report may include a classified section. (b) The Interdiction Committee meets to resolve coordination issues. It reviews the annual plan. It advises the Director on interdiction strategy. The Director picks a Chairperson. Members must meet in person at least once a year, before June 1. Extra meetings can use delegates instead. By September 30 each year, the Chairperson reports to Congress and the Director on the Committee's work. This report may include a classified section. (c) The Director may also help coordinate international drug-control efforts.

facts

- Codified at 21 U.S.C. § 1710, titled "Drug Interdiction Coordinator and Committee," containing 847 words. - Originally enacted as Pub. L. 105–277, div. C, title VII, § 711, added by Pub. L. 109–469, title I, § 103(f)(1), on December 29, 2006 (120 Stat. 3507). - The source credit reflects 5 amendments, including changes by Pub. L. 105–277 § 715 (1998), Pub. L. 109–469 § 602 (2006), and Pub. L. 115–271 §§ 8202(a), (b)(2), 8219 (2018). - The section is organized into three subsections: (a) United States Interdiction Coordinator, (b) Interdiction Committee, and (c) International coordination.

the actual law source: uscode.house.gov ↗public domain

(a) United States Interdiction Coordinator

(1) In general

The Director shall designate or appoint an appointee in the Senior Executive Service or an appointee in a position at level 15 of the General Schedule (or equivalent) as the United States Interdiction Coordinator to perform the duties of that position described in paragraph (2) and such other duties as may be determined by the Director with respect to coordination of efforts to interdict illicit drugs from entering the United States.

(2) Responsibilities

The United States Interdiction Coordinator shall be responsible to the Director for—

(A)

coordinating the interdiction activities of the National Drug Control Program agencies to ensure consistency with the National Drug Control Strategy;

(B)

on behalf of the Director, developing and issuing, on or before September 1 of each year and in accordance with paragraph (4), a National Interdiction Command and Control Plan to ensure the coordination and consistency described in subparagraph (A);

(C)

assessing the sufficiency of assets committed to illicit drug interdiction by the relevant National Drug Control Program agencies; and

(D)

advising the Director on the efforts of each National Drug Control Program agency to implement the National Interdiction Command and Control Plan.

(3) Staff

The Director shall assign such permanent staff of the Office as he considers appropriate to assist the United States Interdiction Coordinator to carry out the responsibilities described in paragraph (2), and may request that appropriate National Drug Control Program agencies detail or assign staff to assist in carrying out such responsibilities.

(4) National Interdiction Command and Control Plan

(A) Purposes

The National Interdiction Command and Control Plan shall—

(i)

set forth the Government’s strategy for drug interdiction;

(ii)

state the specific roles and responsibilities of the relevant National Drug Control Program agencies for implementing that strategy; and

(iii)

identify the specific resources required to enable the relevant National Drug Control Program agencies to implement that strategy.

(B) Consultation with other agencies

Before submission of the National Drug Control Strategy or annual assessment required under section 1705 of this title, as applicable, the United States Interdiction Coordinator shall issue the National Interdiction Command and Control Plan in consultation with the other members of the Interdiction Committee described in subsection (b).

On or before September 1 of each year, the Director, acting through the United States Interdiction Coordinator, shall provide to the appropriate congressional committees, to the Committee on Armed Services and the Committee on Homeland Security of the House of Representatives, and to the Committee on Homeland Security and Governmental Affairs and the Committee on Armed Services of the Senate a report that—

(i)

includes—

(I)

a copy of that year’s National Interdiction Command and Control Plan, including information about how each National Drug Control Program agency conducting drug interdiction activities is engaging with relevant international partners;

(II)

information for the previous 10 years regarding the number and type of seizures of drugs by each National Drug Control Program agency conducting drug interdiction activities and statistical information on the geographic areas of such seizures; and

(III)

information for the previous 10 years regarding the number of air and maritime patrol hours undertaken by each National Drug Control Program agency conducting drug interdiction activities and statistical information on the geographic areas in which such patrol hours took place; and

(ii)

may include recommendations for changes to existing agency authorities or laws governing interagency relationships.

(D) Classified annex

Each report required to be submitted under subparagraph (C) shall be in unclassified form, but may include a classified annex.

(b) Interdiction Committee

(1) In general

The Interdiction Committee shall meet to—

(A)

discuss and resolve issues related to the coordination, oversight and integration of international, border, and domestic drug interdiction efforts in support of the National Drug Control Strategy;

(B)

review the annual National Interdiction Command and Control Plan, and provide advice to the Director and the United States Interdiction Coordinator concerning that plan and how to strengthen international partnerships to better achieve the goals of that plan; and

(C)

provide such other advice to the Director concerning drug interdiction strategy and policies as the committee determines is appropriate.

(2) Chairperson

The Director shall designate one of the members of the Interdiction Committee to serve as Chairperson.

(3) Meetings

The members of the Interdiction Committee shall meet, in person and not through any delegate or representative, at least once per calendar year, before June 1. At the call of the Director or the Chairperson, the Interdiction Committee may hold additional meetings, which shall be attended by the members in person, or through such delegates or representatives as the members may choose.

(4) Report

Not later than September 30 of each year, the Chairperson of the Interdiction Committee shall submit to the Director and to the appropriate congressional committees a report describing the results of the meetings and any significant findings of the Committee during the previous 12 months. The report required under this paragraph shall be in unclassified form, but may include a classified annex.

The Director may facilitate international drug control coordination efforts.

Source credit: (Pub. L. 105–277, div. C, title VII, § 711, as added Pub. L. 109–469, title I, § 103(f)(1), Dec. 29, 2006, 120 Stat. 3507; amended Pub. L. 105–277, div. C, title VII, § 715, Oct. 21, 1998, 112 Stat. 2681–693; Pub. L. 109–469, title VI, § 602, Dec. 29, 2006, 120 Stat. 3533; Pub. L. 115–271, title VIII, §§ 8202(a), (b)(2), 8219, Oct. 24, 2018, 132 Stat. 4110, 4132.)

history & why it existsrecord from the source credit

2006Enacted · Pub. L. 105-277 · 120 Stat. 3507
1998Amended · Pub. L. 105-277 · 112 Stat. 2681
2006Amended · Pub. L. 109-469 · 120 Stat. 3533
2018Amended · Pub. L. 115-271 · 132 Stat. 4110, 4132

The record indicates that this section was originally part of Public Law 105–277, division C, title VII, though the specific provision codified here was added later by Public Law 109–469, title I, § 103(f)(1), enacted December 29, 2006. The source credit also notes an amendment to the original 1998 enactment (Pub. L. 105–277, § 715, Oct. 21, 1998) predating the 2006 addition, followed by further amendments: Public Law 109–469, title VI, § 602 (2006), and Public Law 115–271, title VIII, §§ 8202(a), (b)(2), and 8219 (2018). Taken together, the credit reflects a provision that has been revised multiple times over roughly two decades. Historical context. Public Law 105–277, the omnibus appropriations act for fiscal year 1999, included as one of its divisions the reauthorization of the Office of National Drug Control Policy, the federal office generally understood to coordinate national drug control strategy. Public Law 109–469, enacted in late 2006, is commonly associated with efforts to strengthen accountability and coordination in national drug policy, including interdiction operations along U.S. borders. Public Law 115–271, the SUPPORT for Patients and Communities Act of 2018, is broadly known for addressing the opioid crisis and included provisions refining federal drug-control coordination mechanisms. Beyond this general legislative backdrop, the record does not establish the specific reasoning behind creating the Interdiction Coordinator position or Interdiction Committee described in this section, and no further detail should be inferred.

all 0 arguments · sorted by: best

no arguments yet — make the first case